Invivyd

IPO - NASDAQ:IVVD

Biotech developing antibody-based therapies for viral diseases.
Founder(s)
Laura Walker, Tillman Gerngross
SECTOR(S)
Healthcare
Investment Stage
Growth
Status
IPO/Public

More about Invivyd

No items found.